Cathy N Lam

Array ( [id] => 10573045 [patent_doc_number] => 09295664 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-29 [patent_title] => 'Methods for lowering blood glucose' [patent_app_type] => utility [patent_app_number] => 14/124582 [patent_app_country] => US [patent_app_date] => 2012-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 50 [patent_no_of_words] => 57454 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8394267 [patent_doc_number] => 20120232109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => '3-SUBSTITUTED SULFONYL PIPERIDINE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/478680 [patent_app_country] => US [patent_app_date] => 2012-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32494 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13478680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371376 [patent_doc_number] => 20120220766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'TETRAHYDRO-IMIDAZO[1,5-alpha] PYRAZINE DERIVATIVES, PREPERATION PROCESS AND MEDICINAL USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/463532 [patent_app_country] => US [patent_app_date] => 2012-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31920 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477782 [patent_doc_number] => 20120277188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/461642 [patent_app_country] => US [patent_app_date] => 2012-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13227 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13461642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477781 [patent_doc_number] => 20120277189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'WATER-SOLUBLE BENZOAZEPINE COMPOUND AND ITS PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/461665 [patent_app_country] => US [patent_app_date] => 2012-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13225 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13461665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9319538 [patent_doc_number] => 20140051876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'METHOD FOR MANUFACTURING PHOSPHONOCROTONIC ACID DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 14/113498 [patent_app_country] => US [patent_app_date] => 2012-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10135 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465681 [patent_doc_number] => 20120270849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'COMBINATIONS OF NIACIN, OMEGA-3 AND PLANT STEROLS/STANOLS FOR PREVENTION CHOLESTEROL TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/452111 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4585 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13452111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9422430 [patent_doc_number] => 20140107081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'SALICYLIC ACID TOPICAL FORMULATION' [patent_app_type] => utility [patent_app_number] => 14/008371 [patent_app_country] => US [patent_app_date] => 2012-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16001 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8394203 [patent_doc_number] => 20120232044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING HYPERURICEMIA AND METABOLIC DISORDERS ASSOCIATED WITH HYPERURICEMIA' [patent_app_type] => utility [patent_app_number] => 13/414264 [patent_app_country] => US [patent_app_date] => 2012-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4795 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13414264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760296 [patent_doc_number] => 08420817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 13/412855 [patent_app_country] => US [patent_app_date] => 2012-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21168 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11547300 [patent_doc_number] => 09616123 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-04-11 [patent_title] => 'Method and compound for treatment of menopausal symptoms' [patent_app_type] => utility [patent_app_number] => 13/411660 [patent_app_country] => US [patent_app_date] => 2012-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5341 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13411660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278487 [patent_doc_number] => 20120172358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'GPCR Agonists' [patent_app_type] => utility [patent_app_number] => 13/396193 [patent_app_country] => US [patent_app_date] => 2012-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30675 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13396193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8324475 [patent_doc_number] => 20120196887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'METHODS AND COMPOSITIONS FOR IMPROVED RIFAMYCIN THERAPIES' [patent_app_type] => utility [patent_app_number] => 13/364589 [patent_app_country] => US [patent_app_date] => 2012-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14930 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13364589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209842 [patent_doc_number] => 20120129134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Light-Curable Bone Growth Material for Treating Dental Bone Defects' [patent_app_type] => utility [patent_app_number] => 13/362287 [patent_app_country] => US [patent_app_date] => 2012-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7561 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129134.pdf [firstpage_image] =>[orig_patent_app_number] => 13362287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313631 [patent_doc_number] => 20120190661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION' [patent_app_type] => utility [patent_app_number] => 13/357779 [patent_app_country] => US [patent_app_date] => 2012-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4070 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13357779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9269768 [patent_doc_number] => 20140024686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES' [patent_app_type] => utility [patent_app_number] => 13/980208 [patent_app_country] => US [patent_app_date] => 2012-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15445 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882560 [patent_doc_number] => 08969326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Estrogen antagonists as treatments for sclerosing disorders' [patent_app_type] => utility [patent_app_number] => 13/352602 [patent_app_country] => US [patent_app_date] => 2012-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 7892 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13352602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11177895 [patent_doc_number] => 09409880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-09 [patent_title] => 'Modulators of TLR3/dsRNA complex and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/980874 [patent_app_country] => US [patent_app_date] => 2012-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 18994 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336112 [patent_doc_number] => 20120202816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'NOVEL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/346968 [patent_app_country] => US [patent_app_date] => 2012-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 30243 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13346968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9135570 [patent_doc_number] => 20130296285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'Design of Hydrolytically Releasable Prodrugs for Sustained Release Nanoparticle Formulations' [patent_app_type] => utility [patent_app_number] => 13/976776 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9245 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13976776 [rel_patent_id] =>[rel_patent_doc_number] =>)